{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:47:55Z","timestamp":1792000075622,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ypmed.2026.108643","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:56:10Z","timestamp":1785995770000},"page":"108643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The MOTHER study as a foundation for advancing perinatal opioid use disorder treatment: Clinical guidelines and the evolving research landscape"],"prefix":"10.1016","author":[{"given":"Hendree E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2026.108643_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-244X-14-104","article-title":"Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis","volume":"14","author":"Baldacchino","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ypmed.2026.108643_bb0010","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2026.108643_bb0015","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2026.108643_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","article-title":"Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes","volume":"185","author":"Kaltenbach","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2026.108643_bb0025","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMra1600879","article-title":"Neonatal abstinence syndrome","volume":"375","author":"McQueen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2026.108643_bb0030","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2026.108643_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamainternmed.2023.6986","article-title":"First trimester use of buprenorphine or methadone and the risk of congenital malformations","volume":"184","author":"Suarez","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ypmed.2026.108643_bb0040","series-title":"International Standards for the Treatment of Drug Use Disorders: Revised Edition","author":"United Nations Office on Drugs and Crime","year":"2020"},{"key":"10.1016\/j.ypmed.2026.108643_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2026.0057","article-title":"Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: a randomized clinical trial","author":"Winhusen","year":"2026","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ypmed.2026.108643_bb0050","series-title":"Guidelines for Identification and Management of Substance use and Substance use Disorders in Pregnancy","author":"World Health Organization","year":"2014"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:14:49Z","timestamp":1786533289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743526001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"alternative-id":["S0091743526001490"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108643","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The MOTHER study as a foundation for advancing perinatal opioid use disorder treatment: Clinical guidelines and the evolving research landscape","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108643"}}